Sexual dysfunction and psychotropic medications

CNS Spectrums

Volumn 11, Issue SUPPL. 9, 2006, Pages 24-30

  Stimmel, Glen L ^a   Gutierrez, Mary A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOMIPRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DULOXETINE; ENZYME INDUCING AGENT; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GINKGO BILOBA EXTRACT; IMIPRAMINE; LITHIUM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; OXCARBAZEPINE; PHENELZINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ADJUVANT THERAPY; ANORGASMIA; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG MECHANISM; EJACULATION DISORDER; HUMAN; LIBIDO DISORDER; ORGASM DISORDER; PRIORITY JOURNAL; REVIEW; SEIZURE; SELF REPORT; SEXUAL DYSFUNCTION; SUSTAINED RELEASE PREPARATION;

EID: 33747644344     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900026730     Document Type: Review

References (57)

1. Schiavi RC, Segraves RT. The biology of sexual function. Psychiatr Clin North Am. 1995;18:7-23.
2. Stahl SM. The psychopharmacology of sex. Part 1: Neurotransmitters and the 3 phases of the human sexual response. J Clin Psychiatry. 2001;62:80-81.
3. Stahl SM. The psychopharmacology of sex. Part 2: Effects of drugs and disease on the 3 phases of the human sexual response. J Clin Psychiatry. 2001;62:147-148.
4. Seagraves RT. The effects of minortranquilizers, mood stabilizers, and antipsychotics on sexual function. Primary Psychiatry. 1997;4:46-48.
5. Gitlin M. Sexual dysfunction with psychotropic drugs. Expert Opin Pharmacother. 2003;4:2259-2269.
6. Labbate LA, Grimes J, Hines A, Oleshansky GA, Arana W. Sexual dysfunction induced by serotonin reuptake antidepressants. J Sex Marital Therapy. 1998;24:3-12.
7. Gitlin MJ. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry. 1994;55:406-413.
8. Rothschild AJ. Sexual side effects of antidepressants. J Clin Psychiatry. 2000;61(suppl 11):28-36.
9. Montejo-Gonzalez AL, Liorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997;23:176-194.
10. Michels KB. Problems assessing nonserious adverse drug reactions: antidepressant drug therapy and sexual dysfunction. Pharmacotherapy. 1999;19:424-429.
11. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Zhan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother. 2002;36:1577-1589.
12. Harrison WM, Rabkin JG, Ehrhardt AA, et al. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol. 1986;6:144-149.
13. Crenshaw TL, Goldberg JP. Sexual Pharmacology: Drugs That Affect Sexual Function. New York: W.W. Norton & Company; 1996.
14. Margolese HC, Assalian P. Sexual side effects of antidepressants: a review. J Sex Marital Ther. 1996;22:209-217.
15. Monteiro WO, Noshirvani HF, Marks IM, Lelliott PT. Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. Br J Psychiatry. 1987;151:107-112.
16. Seagraves RT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry. 1998;59(suppl 4):48-54.
17. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999;19:67-85.
18. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry. 2001;62(suppl 3):10-21.
19. Keltner NL, McAfee KM, Taylor CL. Mechanisms and treatments of SSRI-induced sexual dysfunction. Perspect Psychiatr Care. 2002;38:111-116.
20. Stahl SM. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. J Clin Psychiatry. 1998;59(suppl 18):23-29.
21. Gutierrez MA, Stimmel GL. Management of and counseling for psychotropic drug-induced sexual dysfunction. Pharmacotherapy. 1999;19:823-831.
22. Zajecka J. Strategies for the treatment of antidepressant-induced sexual dysfunction. J Clin Psychiatry. 2001;62(suppl 3):35-43.
23. Boyarsky BK, Hirschfeld RM. The management of medication-induced sexual dysfunction. Essent Psychopharmacol. 2000;3:151-170.
24. Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry. 1995;152:1514-1516.
25. Fava M, Rankin M. Sexual functioning and SSRIs. J Clin Psychiatry. 2002;63(suppl 5):13-16.
26. Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry. 1391;52:163-164.
27. Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry. 1992;53:207-209.
28. Eloubeidi MA, Gaede JT, Swaim MW. Reversible nefazodone-induced liver failure. Dig Dis Sci. 2000;45(5):1036-1038.
29. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther. 1998;24:139-143.
30. Balon R. Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther. 1996;22:290-292.
31. Norden MJ. Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Depression. 1994;2:109-112.
32. DeBattista C, Solvason B, Poirier J, et al. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained-release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry. 2005;66:844-848.
33. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 2004;65:62-67.
34. Farah A. Relief of SSRI-induced sexual dysfunction with mirtazapine treatment. J Clin Psychiatry. 1999;60:260-261.
35. Nurnberg HG, Gelenberg AJ, Hargreave TB, Harrison WM, Siegel RL, Smith MD. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry. 2001;158:1926-1928.
36. Nurnberg HG, Hensley P, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA. 2003;289:56-64.
37. Walker PW, Cole JO, Gardner EA, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry. 1993;54:459-465.
38. Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy. 1997;17:10-21.
39. Morrell MJ, Flynn KL, Done S, Flaster E, Kalayjian L, Pack AM. Sexual dysfunction, sex steroid hormone abnormalities, and depression in women with epilepsy treated with antiepileptic drugs. Epilepsy Behav. 2005;6:360-365.
40. Penovich PE. The effects of epilepsy and its treatment on sexual and reproductive function. Epilepsia. 2000;41(suppl 2):S53-S61.
41. Herzog AG, Drislane FW, Schomer DL, et al. Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy. Epilepsia. 2004;45:764-768.
42. Herzog AG, Fowler KM. Sexual hormones and epilepsy: threat and opportunities. Curr Opin Neurol. 2005;18:167-172.
43. Labbate LA, Rubey RN. Gabapentin-induced ejaculatory failure and anorgasmia. Am J Psychiatry. 1999;156:972.
44. Grant AC, Oh H. Gabapentin-induced anorgasmia in women [letter]. Am J Psychiatry. 2002;159:1247.
45. Newman LC, Broner SW, Lay CL. Reversible anorgasmia with topiramate therapy for migraine. Neurology. 2005;65:1333-1334.
46. Holtkamp M, Weissinger F, Meierkord H. Erectile dysfunction with topiramate. Epilepsia. 2005;46:166-167.
47. Hitiris N, Barrett JA, Brodie MJ. Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports. Epilepsy Behav. 2006;8:418-421.
48. Gil-Nagel A, Lopez-Munoz F, Serratosa JM, Moncada I, Garcia-Garcia P, Alamo C. Effect of lamotrigine on sexual function in patients with epilepsy. Seizure. 2006;15:142-149.
49. Ghadirian AM, Annable L, Belanger MC. Lithium, benzodiazepines, and sexual function in bipolar patients. Am J Psychiatry. 1992;149:801-805.
50. Melkersson K. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients. J Clin Psychiatry. 2005;66:761-767.
51. Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinemia: mechanisms, clinical features, and management. Drugs. 2004;64:2291-2314.
52. Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry. 2002;181:49-55.
53. Bobes J, Garca-Portilla MP, Rejas J, et al. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther. 2003;29:125-147.
54. Shiwach RS, Carmody TJ. Prolactogenic effects of risperidone in male patients-a preliminary study. Acts Psychiatr Scand. 1998;98:81-83.
55. Byerly MJ, Lescouflair E, Weber MT, et al. An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction. J Sex Marital Ther. 2004;30:325-332.
56. Cavallaro R, Cocchi F, Angelone SM, Lattuada E, Smeraldi E. Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study. J Clin Psychiatry. 2004;65:187-190.
57. Gopalakrishnan R, Jacob KS, Kuruvilla A, Basantharaj B, John JK. Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible dose, two-way crossover trial. Am J Psychiatry. 2006;163:494-499.